노르웨이 -
노르웨이어 -
Statens legemiddelverk
seloken 1 mg/ ml
recordati ireland limited - metoprololtartrat - injeksjonsvæske, oppløsning - 1 mg/ ml
노르웨이 -
노르웨이어 -
Statens legemiddelverk
tambocor 10 mg/ ml
viatris as - flekainidacetat - injeksjonsvæske, oppløsning - 10 mg/ ml
노르웨이 -
노르웨이어 -
Statens legemiddelverk
taptiqom 15 mikrog/ ml / 5 mg/ ml
santen oy - tafluprost / timololmaleat - Øyedråper, oppløsning i endosebeholder - 15 mikrog/ ml / 5 mg/ ml
노르웨이 -
노르웨이어 -
Statens legemiddelverk
zanidip 10 mg
recordati ireland limited - lerkanidipinhydroklorid - tablett, filmdrasjert - 10 mg
노르웨이 -
노르웨이어 -
Statens legemiddelverk
zanidip 20 mg
recordati ireland limited - lerkanidipinhydroklorid - tablett, filmdrasjert - 20 mg
유럽 연합 -
노르웨이어 -
EMA (European Medicines Agency)
silodosin recordati
recordati ireland ltd - silodosin - prostatisk hyperplasi - urologicals, alfa-antagonister adrenoreceptor - behandling av tegn og symptomer på godartet prostatahyperplasi (bph) hos voksne menn.
유럽 연합 -
노르웨이어 -
EMA (European Medicines Agency)
prehevbri
vbi vaccines b.v. - hepatitt b overflate antigen - hepatitt b - vaksiner - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.
노르웨이 -
노르웨이어 -
Statens legemiddelverk
taptiqom sine 15 mikrog/ ml / 5 mg/ ml
santen oy (1) - tafluprost / timololmaleat - Øyedråper, oppløsning - 15 mikrog/ ml / 5 mg/ ml
유럽 연합 -
노르웨이어 -
EMA (European Medicines Agency)
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.